Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 13 entries
Sorted by: Best Match Show Resources per page
Political, social and institutional barriers to environmental information : A commentary.

Environmental monitoring and assessment

Desbarats P.
PMID: 24234122
Environ Monit Assess. 1992 Mar;20(2):213-6. doi: 10.1007/BF00407515.

No abstract available.

Cite
Desbarats P. Political, social and institutional barriers to environmental information : A commentary. Environ Monit Assess. 1992;20(2):213-6doi: 10.1007/BF00407515.
Desbarats, P. (1992). Political, social and institutional barriers to environmental information : A commentary. Environmental monitoring and assessment, 20(2), 213-6. https://doi.org/10.1007/BF00407515
Desbarats, P. "Political, social and institutional barriers to environmental information : A commentary." Environmental monitoring and assessment vol. 20,2 (1992): 213-6. doi: https://doi.org/10.1007/BF00407515
Desbarats P. Political, social and institutional barriers to environmental information : A commentary. Environ Monit Assess. 1992 Mar;20(2):213-6. doi: 10.1007/BF00407515. PMID: 24234122.
Copy Download .nbib Format: NLM
Developing inclusive design expertise within a client/consultancy relationship.

Applied ergonomics

Warburton N, Desbarats G, Hosking I.
PMID: 23726278
Appl Ergon. 2015 Jan;46:274-8. doi: 10.1016/j.apergo.2013.03.010. Epub 2013 May 28.

TheAlloy have been working together with British Telecom (BT), as their product design consultants, for over ten years. During that time BT have undergone a key transformation which has had a profound impact on their design focus. This transformation...

Cite
Warburton N, Desbarats G, Hosking I. Developing inclusive design expertise within a client/consultancy relationship. Appl Ergon. 2013;46:274-8doi: 10.1016/j.apergo.2013.03.010.
Warburton, N., Desbarats, G., & Hosking, I. (2015). Developing inclusive design expertise within a client/consultancy relationship. Applied ergonomics, 46274-8. https://doi.org/10.1016/j.apergo.2013.03.010
Warburton, Nina, et al. "Developing inclusive design expertise within a client/consultancy relationship." Applied ergonomics vol. 46 (2015): 274-8. doi: https://doi.org/10.1016/j.apergo.2013.03.010
Warburton N, Desbarats G, Hosking I. Developing inclusive design expertise within a client/consultancy relationship. Appl Ergon. 2015 Jan;46:274-8. doi: 10.1016/j.apergo.2013.03.010. Epub 2013 May 28. PMID: 23726278.
Copy Download .nbib Format: NLM
How to set up a database?-a five-step process.

Journal of thoracic disease

Brembilla A, Martin B, Parmentier AL, Desmarets M, Falcoz PE, Puyraveau M, Mauny F.
PMID: 30510791
J Thorac Dis. 2018 Oct;10:S3533-S3538. doi: 10.21037/jtd.2018.09.138.

Database set-up directly impacts the quality and viability of research data, and therefore is a crucial part of the quality of clinical research. Setting up a quality database implies following a strict data-management process. Too much collected information threatens...

Cite
Brembilla A, Martin B, Parmentier AL, et al. How to set up a database?-a five-step process. J Thorac Dis. 2018;10:S3533-S3538doi: 10.21037/jtd.2018.09.138.
Brembilla, A., Martin, B., Parmentier, A. L., Desmarets, M., Falcoz, P. E., Puyraveau, M., & Mauny, F. (2018). How to set up a database?-a five-step process. Journal of thoracic disease, 10S3533-S3538. https://doi.org/10.21037/jtd.2018.09.138
Brembilla, Alice, et al. "How to set up a database?-a five-step process." Journal of thoracic disease vol. 10 (2018): S3533-S3538. doi: https://doi.org/10.21037/jtd.2018.09.138
Brembilla A, Martin B, Parmentier AL, Desmarets M, Falcoz PE, Puyraveau M, Mauny F. How to set up a database?-a five-step process. J Thorac Dis. 2018 Oct;10:S3533-S3538. doi: 10.21037/jtd.2018.09.138. PMID: 30510791; PMCID: PMC6230828.
Copy Download .nbib Format: NLM
Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation.

Transplantation

Shaked O, Demetris J, Levitsky J, Feng S, Loza BL, Punch J, Reyes J, Klintmalm G, Jackson W, DesMarais M, Sayre P, Shaked A, Reddy KR.
PMID: 33982909
Transplantation. 2022 Jan 01;106(1):106-116. doi: 10.1097/TP.0000000000003681.

BACKGROUND: Deceased donor and recipient predictors of posttransplant steatosis/steatohepatitis and fibrosis are not well known. Our aim was to evaluate the prevalence and assess donor and recipient predictors of steatosis, steatohepatitis, and fibrosis in liver transplantation recipients.METHODS: Using the...

Cite
Shaked O, Demetris J, Levitsky J, et al. Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation. Transplantation. 2022;106(1):106-116doi: 10.1097/TP.0000000000003681.
Shaked, O., Demetris, J., Levitsky, J., Feng, S., Loza, B. L., Punch, J., Reyes, J., Klintmalm, G., Jackson, W., DesMarais, M., Sayre, P., Shaked, A., & Reddy, K. R. (2022). Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation. Transplantation, 106(1), 106-116. https://doi.org/10.1097/TP.0000000000003681
Shaked, Oren, et al. "Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation." Transplantation vol. 106,1 (2022): 106-116. doi: https://doi.org/10.1097/TP.0000000000003681
Shaked O, Demetris J, Levitsky J, Feng S, Loza BL, Punch J, Reyes J, Klintmalm G, Jackson W, DesMarais M, Sayre P, Shaked A, Reddy KR. Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation. Transplantation. 2022 Jan 01;106(1):106-116. doi: 10.1097/TP.0000000000003681. PMID: 33982909; PMCID: PMC8349377.
Copy Download .nbib Format: NLM
Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells.

Journal of nanobiotechnology

Choi AO, Cho SJ, Desbarats J, Lovrić J, Maysinger D.
PMID: 17295922
J Nanobiotechnology. 2007 Feb 12;5:1. doi: 10.1186/1477-3155-5-1.

BACKGROUND: Neuroblastoma, a frequently occurring solid tumour in children, remains a therapeutic challenge as existing imaging tools are inadequate for proper and accurate diagnosis, resulting in treatment failures. Nanoparticles have recently been introduced to the field of cancer research...

Cite
Choi AO, Cho SJ, Desbarats J, et al. Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells. J Nanobiotechnology. 2007;5:1doi: 10.1186/1477-3155-5-1.
Choi, A. O., Cho, S. J., Desbarats, J., Lovrić, J., & Maysinger, D. (2007). Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells. Journal of nanobiotechnology, 51. https://doi.org/10.1186/1477-3155-5-1
Choi, Angela O, et al. "Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells." Journal of nanobiotechnology vol. 5 (2007): 1. doi: https://doi.org/10.1186/1477-3155-5-1
Choi AO, Cho SJ, Desbarats J, Lovrić J, Maysinger D. Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells. J Nanobiotechnology. 2007 Feb 12;5:1. doi: 10.1186/1477-3155-5-1. PMID: 17295922; PMCID: PMC1802956.
Copy Download .nbib Format: NLM
Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation.

Transplantation

Shaked O, Demetris J, Levitsky J, Feng S, Loza BL, Punch J, Reyes J, Klintmalm G, Jackson W, DesMarais M, Sayre P, Shaked A, Reddy KR.
PMID: 33982909
Transplantation. 2021 Feb 08; doi: 10.1097/TP.0000000000003681. Epub 2021 Feb 08.

BACKGROUND: Deceased donor and recipient predictors of post transplant steatosis/steatohepatitis and fibrosis are not well known.AIM: Evaluate the prevalence and assess donor and recipient predictors of steatosis, steatohepatitis, and fibrosis in LT recipients.METHODS: Using the ITN A-WISH multicenter study...

Cite
Shaked O, Demetris J, Levitsky J, et al. Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation. Transplantation. 2021;doi: 10.1097/TP.0000000000003681.
Shaked, O., Demetris, J., Levitsky, J., Feng, S., Loza, B. L., Punch, J., Reyes, J., Klintmalm, G., Jackson, W., DesMarais, M., Sayre, P., Shaked, A., & Reddy, K. R. (2021). Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation. Transplantation, . https://doi.org/10.1097/TP.0000000000003681
Shaked, Oren, et al. "Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation." Transplantation vol. (2021). doi: https://doi.org/10.1097/TP.0000000000003681
Shaked O, Demetris J, Levitsky J, Feng S, Loza BL, Punch J, Reyes J, Klintmalm G, Jackson W, DesMarais M, Sayre P, Shaked A, Reddy KR. Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation. Transplantation. 2021 Feb 08; doi: 10.1097/TP.0000000000003681. Epub 2021 Feb 08. PMID: 33982909; PMCID: PMC8349377.
Copy Download .nbib Format: NLM
Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation.

Transplantation

Shaked O, Demetris J, Levitsky J, Feng S, Loza BL, Punch J, Reyes J, Klintmalm G, Jackson W, DesMarais M, Sayre P, Shaked A, Reddy KR.
PMID: 33982909
Transplantation. 2022 Jan 01;106(1):106-116. doi: 10.1097/TP.0000000000003681.

BACKGROUND: Deceased donor and recipient predictors of posttransplant steatosis/steatohepatitis and fibrosis are not well known. Our aim was to evaluate the prevalence and assess donor and recipient predictors of steatosis, steatohepatitis, and fibrosis in liver transplantation recipients.METHODS: Using the...

Cite
Shaked O, Demetris J, Levitsky J, et al. Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation. Transplantation. 2022;106(1):106-116doi: 10.1097/TP.0000000000003681.
Shaked, O., Demetris, J., Levitsky, J., Feng, S., Loza, B. L., Punch, J., Reyes, J., Klintmalm, G., Jackson, W., DesMarais, M., Sayre, P., Shaked, A., & Reddy, K. R. (2022). Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation. Transplantation, 106(1), 106-116. https://doi.org/10.1097/TP.0000000000003681
Shaked, Oren, et al. "Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation." Transplantation vol. 106,1 (2022): 106-116. doi: https://doi.org/10.1097/TP.0000000000003681
Shaked O, Demetris J, Levitsky J, Feng S, Loza BL, Punch J, Reyes J, Klintmalm G, Jackson W, DesMarais M, Sayre P, Shaked A, Reddy KR. Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation. Transplantation. 2022 Jan 01;106(1):106-116. doi: 10.1097/TP.0000000000003681. PMID: 33982909; PMCID: PMC8349377.
Copy Download .nbib Format: NLM
Fas ligand: receptor or ligand?.

Apoptosis : an international journal on programmed cell death

Newell MK, Desbarats J.
PMID: 14634333
Apoptosis. 1999 Oct;4(5):311-5. doi: 10.1023/a:1009670802382.

In this review, we chronicle the discovery, biochemical characterization, and assignment of Fas (CD95) as receptor and Fas Ligand (FasL, CD95L) as ligand. We review the functional descriptions of the molecules as death-inducing receptor and ligand or as mediators...

Cite
Newell MK, Desbarats J. Fas ligand: receptor or ligand?. Apoptosis. 1999;4(5):311-5doi: 10.1023/a:1009670802382.
Newell, M. K., & Desbarats, J. (1999). Fas ligand: receptor or ligand?. Apoptosis : an international journal on programmed cell death, 4(5), 311-5. https://doi.org/10.1023/a:1009670802382
Newell, M K, and Desbarats, J. "Fas ligand: receptor or ligand?." Apoptosis : an international journal on programmed cell death vol. 4,5 (1999): 311-5. doi: https://doi.org/10.1023/a:1009670802382
Newell MK, Desbarats J. Fas ligand: receptor or ligand?. Apoptosis. 1999 Oct;4(5):311-5. doi: 10.1023/a:1009670802382. PMID: 14634333.
Copy Download .nbib Format: NLM
Fas expression promotes proteasomal activity in toxin-induced parkinsonism.

Acta neuropsychiatrica

Landau AM, Siegrist-Johnstone R, Desbarats J.
PMID: 26953010
Acta Neuropsychiatr. 2012 Jun;24(3):166-71. doi: 10.1111/j.1601-5215.2011.00615.x.

OBJECTIVE: Fas (CD95), commonly categorised as a death receptor due to its well-defined role in apoptosis, can paradoxically also promote neuroprotection. We have previously found that defects in Fas signalling render mice highly susceptible to neural degeneration in the...

Cite
Landau AM, Siegrist-Johnstone R, Desbarats J. Fas expression promotes proteasomal activity in toxin-induced parkinsonism. Acta Neuropsychiatr. 2012;24(3):166-71doi: 10.1111/j.1601-5215.2011.00615.x.
Landau, A. M., Siegrist-Johnstone, R., & Desbarats, J. (2012). Fas expression promotes proteasomal activity in toxin-induced parkinsonism. Acta neuropsychiatrica, 24(3), 166-71. https://doi.org/10.1111/j.1601-5215.2011.00615.x
Landau, Anne M, et al. "Fas expression promotes proteasomal activity in toxin-induced parkinsonism." Acta neuropsychiatrica vol. 24,3 (2012): 166-71. doi: https://doi.org/10.1111/j.1601-5215.2011.00615.x
Landau AM, Siegrist-Johnstone R, Desbarats J. Fas expression promotes proteasomal activity in toxin-induced parkinsonism. Acta Neuropsychiatr. 2012 Jun;24(3):166-71. doi: 10.1111/j.1601-5215.2011.00615.x. PMID: 26953010.
Copy Download .nbib Format: NLM
Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation.

Transplantation

Shaked O, Demetris J, Levitsky J, Feng S, Loza BL, Punch J, Reyes J, Klintmalm G, Jackson W, DesMarais M, Sayre P, Shaked A, Reddy KR.
PMID: 33982909
Transplantation. 2022 Jan 01;106(1):106-116. doi: 10.1097/TP.0000000000003681.

BACKGROUND: Deceased donor and recipient predictors of posttransplant steatosis/steatohepatitis and fibrosis are not well known. Our aim was to evaluate the prevalence and assess donor and recipient predictors of steatosis, steatohepatitis, and fibrosis in liver transplantation recipients.METHODS: Using the...

Cite
Shaked O, Demetris J, Levitsky J, et al. Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation. Transplantation. 2022;106(1):106-116doi: 10.1097/TP.0000000000003681.
Shaked, O., Demetris, J., Levitsky, J., Feng, S., Loza, B. L., Punch, J., Reyes, J., Klintmalm, G., Jackson, W., DesMarais, M., Sayre, P., Shaked, A., & Reddy, K. R. (2022). Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation. Transplantation, 106(1), 106-116. https://doi.org/10.1097/TP.0000000000003681
Shaked, Oren, et al. "Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation." Transplantation vol. 106,1 (2022): 106-116. doi: https://doi.org/10.1097/TP.0000000000003681
Shaked O, Demetris J, Levitsky J, Feng S, Loza BL, Punch J, Reyes J, Klintmalm G, Jackson W, DesMarais M, Sayre P, Shaked A, Reddy KR. Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation. Transplantation. 2022 Jan 01;106(1):106-116. doi: 10.1097/TP.0000000000003681. PMID: 33982909; PMCID: PMC8349377.
Copy Download .nbib Format: NLM
Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation.

Transplantation

Shaked O, Demetris J, Levitsky J, Feng S, Loza BL, Punch J, Reyes J, Klintmalm G, Jackson W, DesMarais M, Sayre P, Shaked A, Reddy KR.
PMID: 33982909
Transplantation. 2022 Jan 01;106(1):106-116. doi: 10.1097/TP.0000000000003681.

BACKGROUND: Deceased donor and recipient predictors of posttransplant steatosis/steatohepatitis and fibrosis are not well known. Our aim was to evaluate the prevalence and assess donor and recipient predictors of steatosis, steatohepatitis, and fibrosis in liver transplantation recipients.METHODS: Using the...

Cite
Shaked O, Demetris J, Levitsky J, et al. Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation. Transplantation. 2022;106(1):106-116doi: 10.1097/TP.0000000000003681.
Shaked, O., Demetris, J., Levitsky, J., Feng, S., Loza, B. L., Punch, J., Reyes, J., Klintmalm, G., Jackson, W., DesMarais, M., Sayre, P., Shaked, A., & Reddy, K. R. (2022). Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation. Transplantation, 106(1), 106-116. https://doi.org/10.1097/TP.0000000000003681
Shaked, Oren, et al. "Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation." Transplantation vol. 106,1 (2022): 106-116. doi: https://doi.org/10.1097/TP.0000000000003681
Shaked O, Demetris J, Levitsky J, Feng S, Loza BL, Punch J, Reyes J, Klintmalm G, Jackson W, DesMarais M, Sayre P, Shaked A, Reddy KR. Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation. Transplantation. 2022 Jan 01;106(1):106-116. doi: 10.1097/TP.0000000000003681. PMID: 33982909; PMCID: PMC8349377.
Copy Download .nbib Format: NLM
Investigation on reconstruction methods applied to 3D terahertz computed tomography.

Optics express

Recur B, Younus A, Salort S, Mounaix P, Chassagne B, Desbarats P, Caumes JP, Abraham E.
PMID: 21445145
Opt Express. 2011 Mar 14;19(6):5105-17. doi: 10.1364/OE.19.005105.

3D terahertz computed tomography has been performed using a monochromatic millimeter wave imaging system coupled with an infrared temperature sensor. Three different reconstruction methods (standard back-projection algorithm and two iterative analysis) have been compared in order to reconstruct large...

Cite
Recur B, Younus A, Salort S, et al. Investigation on reconstruction methods applied to 3D terahertz computed tomography. Opt Express. 2011;19(6):5105-17doi: 10.1364/OE.19.005105.
Recur, B., Younus, A., Salort, S., Mounaix, P., Chassagne, B., Desbarats, P., Caumes, J. P., & Abraham, E. (2011). Investigation on reconstruction methods applied to 3D terahertz computed tomography. Optics express, 19(6), 5105-17. https://doi.org/10.1364/OE.19.005105
Recur, B, et al. "Investigation on reconstruction methods applied to 3D terahertz computed tomography." Optics express vol. 19,6 (2011): 5105-17. doi: https://doi.org/10.1364/OE.19.005105
Recur B, Younus A, Salort S, Mounaix P, Chassagne B, Desbarats P, Caumes JP, Abraham E. Investigation on reconstruction methods applied to 3D terahertz computed tomography. Opt Express. 2011 Mar 14;19(6):5105-17. doi: 10.1364/OE.19.005105. PMID: 21445145.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 13 entries